Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.47 USD 0.00(0%)
Last update at 2026-11-19T21:00:00Z
VOLUME
5001
Market Cap
9.79M
P/E
6.07

Momentum Score

…

Bio Essence Corporation engages in manufacturing and distributing health supplement products. It also offers original equipment manufacturing, and private label services for dietary supplements, vitamins, and herbal nutrition products. Bio Essence Corporation was incorporated in 2000 and is headquartered in Irvine, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.47
Low
0.47
High
52 Week Price Range
0.05
Low
0.52
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.47
Dividend Yield
-
Revenue TTM
2.91M
Revenue Per Share
0.07
Gross Profit TTM
2.03M
Debt / Equity
-0.75
ROE
-
Net Debt
1.56M
ROCE
-44.62%
Diluted EPS TTM
0.03

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 0.90M -1.56M -0.80M -0.81M -0.64M
Net income 0.90M -1.31M -0.97M -0.81M -0.65M
Selling general administrative 0.50M 0.68M 0.97M 1.17M 1.15M
Selling and marketing expenses 0.03M - 0.09M - -
Gross profit 1.43M 0.22M 0.28M 0.38M 0.30M
Reconciled depreciation 0.00M 0.00M 0.02M 0.05M 0.04M
Ebit 0.90M -1.56M -0.78M - -0.86M
Ebitda 0.90M -1.56M -0.77M -0.73M -0.57M
Depreciation and amortization 0.00M 0.00M 0.02M - -
Operating income 0.90M -0.46M -0.79M -0.78M -0.85M
Other operating expenses 1.00M 0.78M 1.34M - -
Interest expense 0.00M 0.00M 0.02M 0.02M 0.04M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Net interest income -0.00M -0.00M -0.02M -0.03M -0.05M
Income tax expense 0.00M 0.00M 0.00M - 0.00M
Total revenue 1.90M 0.32M 0.55M 0.99M 0.89M
Total operating expenses 0.53M 0.68M 1.07M 1.77M 1.74M
Cost of revenue 0.47M 0.11M 0.27M 0.60M 0.59M
Total other income expense net -0.00M -1.11M -0.01M 0.00M 0.25M
Net income from continuing ops 0.90M -1.57M -0.80M -0.81M -0.65M
Net income applicable to common shares - - - - -0.65M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 0.42M 0.28M 2.66M 1.55M 1.70M
Intangible assets 0.00M 0.00M 0.00M 0.00M 0.00M
Other current assets 0.40M 0.27M 0.01M - -
Total liab 2.50M 3.25M 4.32M 4.79M 4.13M
Total stockholder equity -2.07M -2.97M -1.66M -3.24M -2.43M
Other current liab 0.04M 0.34M 0.67M - 0.07M
Common stock 0.00M 0.00M 0.00M - 0.00M
Capital stock 0.00M 0.00M 0.00M 0.00M 0.00M
Retained earnings -9.55M -10.45M -9.14M -8.17M -7.36M
Other assets - - - - 0.04M
Cash 0.00M 0.00M 0.00M 0.01M 0.00M
Total current liabilities 2.44M 2.80M 3.18M 3.56M 2.76M
Current deferred revenue 0.85M 0.19M - - -
Net debt 1.56M 2.70M 3.48M 3.45M 2.68M
Short term debt 1.51M 2.26M 2.34M - -
Short long term debt 0.00M 1.19M 1.84M 3.22M 2.43M
Short long term debt total 1.56M 2.70M 3.48M - -
Other stockholder equity 7.48M 7.48M 7.48M - -
Property plant equipment - - - - 1.39M
Total current assets 0.42M 0.28M 1.10M 0.20M 0.26M
Net tangible assets - - - - -2.43M
Net receivables 0.02M 0.01M 0.95M 0.01M 0.02M
Long term debt 0.06M 0.06M 0.20M 0.24M 0.25M
Inventory - - 0.14M 0.18M 0.21M
Accounts payable 0.05M 0.02M 0.17M 0.05M 0.06M
Non currrent assets other - - 0.09M - -
Non current assets total 0.00M 0.00M 1.56M 1.34M 1.44M
Capital lease obligations 1.50M 1.46M 1.44M 1.16M 1.28M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.00M -0.09M -0.06M -0.12M
Change to liabilities - - - - 0.01M
Total cashflows from investing activities - -0.00M -0.09M - -0.12M
Net borrowings -1.67M -0.61M 1.18M - 1.41M
Total cash from financing activities -1.57M -0.62M 1.11M 0.77M 1.41M
Change to operating activities - - - - -0.76M
Net income 0.90M -1.31M -0.80M -0.81M -0.65M
Change in cash -0.00M 0.00M -0.01M 0.01M -0.01M
Begin period cash flow 0.00M 0.00M 0.01M 0.00M 0.01M
End period cash flow 0.00M 0.00M 0.00M 0.01M 0.00M
Total cash from operating activities 1.57M 0.62M -1.03M -0.71M -1.29M
Depreciation 0.00M 0.00M 0.02M 0.05M 0.04M
Other cashflows from investing activities - -0.00M -0.09M - -
Change to inventory - - -0.01M 0.03M 0.06M
Change to account receivables 0.18M 0.50M -0.01M 0.01M 0.02M
Other cashflows from financing activities -1.57M -0.01M -0.04M - -
Change to netincome - - - - -0.01M
Capital expenditures 0.00M 0.00M 0.00M 0.06M 0.12M
Change in working capital 0.63M 0.87M -0.07M 0.07M -0.45M
Stock based compensation - - - - 0.00M
Other non cash items 0.04M 1.07M -0.17M -0.02M -0.24M
Free cash flow 1.57M 0.62M -1.03M -0.77M -1.41M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BIOE
Bio Essence Corporation
-
-%
0.47 6.07 - 3.36 4.18 3.90 6.92
MKKGY
Merck KGaA ADR
-0.68
2.09%
31.83 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-
-%
163.45 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR
0.38
1.77%
21.79 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.
-
-%
43.05 - 10.66 0.01 1.16 2.94 23.11

Profile*

Bio Essence Corporation

Bio Essence Corporation engages in manufacturing and distributing health supplement products. It also offers original equipment manufacturing, and private label services for dietary supplements, vitamins, and herbal nutrition products. Bio Essence Corporation was incorporated in 2000 and is headquartered in Irvine, California.

2955 Main Street, Irvine, CA, United States, 92618

949 706 9966

4

Name Title Year Born
Ms. Yin Yan CEO, CFO & Chairman 1975
Mr. Tuan Tran VP of Operations 1975
Ms. Yin Yan CEO, Chief Accounting Officer & Chairman of the Board 1976
Yuling Huang Accounting Manager NA
Ji Ping Rong Operation Manager NA
Mr. William E. Sluss CFO & Director 1955
Mr. Tuan Tran Vice President of Operations 1974
Ms. Yin Yan J.D., M.B.A. CEO, Controller, Chief Accounting Officer & Chairman of the Board 1976
Wenwen He Accounting Assistant NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…